Home

equatore Padronanza Presidente egfr basso civiltà tappeto Tipico

eGFR alto, basso e valori normali
eGFR alto, basso e valori normali

The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival  of patients with non-small-cell lung cancer | PLOS ONE
The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer | PLOS ONE

Resistance to epidermal growth factor receptor inhibition in non-small cell  lung cancer
Resistance to epidermal growth factor receptor inhibition in non-small cell lung cancer

Non-classic EGFR mutations in a cohort of Dutch EGFR-mutated NSCLC patients  and outcomes following EGFR-TKI treatment | British Journal of Cancer
Non-classic EGFR mutations in a cohort of Dutch EGFR-mutated NSCLC patients and outcomes following EGFR-TKI treatment | British Journal of Cancer

Understanding resistance to EGFR inhibitors—impact on future treatment  strategies | Nature Reviews Clinical Oncology
Understanding resistance to EGFR inhibitors—impact on future treatment strategies | Nature Reviews Clinical Oncology

Epidermal growth factor receptor mutations in lung cancer | Nature Reviews  Cancer
Epidermal growth factor receptor mutations in lung cancer | Nature Reviews Cancer

Epidermal Growth Factor Receptor (EGFR) Antibody Down-regulates Mutant  Receptors and Inhibits Tumors Expressing EGFR Mutations* - Journal of  Biological Chemistry
Epidermal Growth Factor Receptor (EGFR) Antibody Down-regulates Mutant Receptors and Inhibits Tumors Expressing EGFR Mutations* - Journal of Biological Chemistry

Unraveling the differential impact of PAHs and dioxin-like compounds on  AKR1C3 reveals the EGFR extracellular domain as a critical determinant of  the AHR response - ScienceDirect
Unraveling the differential impact of PAHs and dioxin-like compounds on AKR1C3 reveals the EGFR extracellular domain as a critical determinant of the AHR response - ScienceDirect

EGFR targeting for cancer therapy: Pharmacology and immunoconjugates with  drugs and nanoparticles - ScienceDirect
EGFR targeting for cancer therapy: Pharmacology and immunoconjugates with drugs and nanoparticles - ScienceDirect

EGFR-TKIs resistance via EGFR-independent signaling pathways | Molecular  Cancer | Full Text
EGFR-TKIs resistance via EGFR-independent signaling pathways | Molecular Cancer | Full Text

Calcolo ed interpretazione pratica della Funzionalitá Renale | FIMMG  Piemonte
Calcolo ed interpretazione pratica della Funzionalitá Renale | FIMMG Piemonte

Neuregulin 1–activated ERBB4 as a “dedicated” receptor for the Hippo-YAP  pathway | Science Signaling
Neuregulin 1–activated ERBB4 as a “dedicated” receptor for the Hippo-YAP pathway | Science Signaling

Resistance to epidermal growth factor receptor inhibition in non-small cell  lung cancer
Resistance to epidermal growth factor receptor inhibition in non-small cell lung cancer

Inhibition of Brain Epidermal Growth Factor Receptor Activation: A Novel  Target in Neurodegenerative Diseases and Brain Injuries | Molecular  Pharmacology
Inhibition of Brain Epidermal Growth Factor Receptor Activation: A Novel Target in Neurodegenerative Diseases and Brain Injuries | Molecular Pharmacology

Combined assessment of EGFR pathway-related molecular markers and prognosis  of NSCLC patients | British Journal of Cancer
Combined assessment of EGFR pathway-related molecular markers and prognosis of NSCLC patients | British Journal of Cancer

Differential roles of ERRFI1 in EGFR and AKT pathway regulation affect  cancer proliferation | EMBO reports
Differential roles of ERRFI1 in EGFR and AKT pathway regulation affect cancer proliferation | EMBO reports

EGFR targeting for cancer therapy: Pharmacology and immunoconjugates with  drugs and nanoparticles - ScienceDirect
EGFR targeting for cancer therapy: Pharmacology and immunoconjugates with drugs and nanoparticles - ScienceDirect

Beyond EGFR inhibition: multilateral combat strategies to stop the  progression of head and neck cancer | Experimental & Molecular Medicine
Beyond EGFR inhibition: multilateral combat strategies to stop the progression of head and neck cancer | Experimental & Molecular Medicine

Velocità di Filtrazione Glomerulare - eGFR
Velocità di Filtrazione Glomerulare - eGFR

Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling  pathways and targeted therapies | Oncogene
Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies | Oncogene

Treatment Options for EGFR T790M-Negative EGFR Tyrosine Kinase  Inhibitor-Resistant Non-Small Cell Lung Cancer | SpringerLink
Treatment Options for EGFR T790M-Negative EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer | SpringerLink

The miR‑625‑3p/AXL axis induces non‑T790M acquired resistance to EGFR‑TKI  via activation of the TGF‑β/Smad pathway and EMT in EGFR‑mutant non‑small  cell lung cancer
The miR‑625‑3p/AXL axis induces non‑T790M acquired resistance to EGFR‑TKI via activation of the TGF‑β/Smad pathway and EMT in EGFR‑mutant non‑small cell lung cancer

eGFR: l'indicatore della salute dei reni. I valori e cosa significa se è  basso
eGFR: l'indicatore della salute dei reni. I valori e cosa significa se è basso

Promotion or remission: a role of noncoding RNAs in colorectal cancer  resistance to anti-EGFR therapy | Cell Communication and Signaling | Full  Text
Promotion or remission: a role of noncoding RNAs in colorectal cancer resistance to anti-EGFR therapy | Cell Communication and Signaling | Full Text

Novel therapeutic strategies targeting the epidermal growth factor receptor  (EGFR) family and its downstream effectors in breast cancer - Annals of  Oncology
Novel therapeutic strategies targeting the epidermal growth factor receptor (EGFR) family and its downstream effectors in breast cancer - Annals of Oncology

Structural analysis of the EGFR/HER3 heterodimer reveals the molecular  basis for activating HER3 mutations | Science Signaling
Structural analysis of the EGFR/HER3 heterodimer reveals the molecular basis for activating HER3 mutations | Science Signaling

Improvement and extension of anti-EGFR targeting in breast cancer therapy  by integration with the Avidin-Nucleic-Acid-Nano-Assemblies | Nature  Communications
Improvement and extension of anti-EGFR targeting in breast cancer therapy by integration with the Avidin-Nucleic-Acid-Nano-Assemblies | Nature Communications

The epidermal growth factor receptor variant III (EGFRvIII): where wild  things are altered - Gan - 2013 - The FEBS Journal - Wiley Online Library
The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered - Gan - 2013 - The FEBS Journal - Wiley Online Library